Blue light therapy shown to improve sleep in Parkinson's

A study has shown that the therapy is safe, usable and may improve daytime sleepiness in Parkinson's.

Many people with Parkinson's experience trouble with sleep. This can involve finding it difficult to fall asleep, waking up in the night, or feeling sleepy throughout the day. Over time, it can significantly reduce quality of life. Early research has shown that blue light therapy, delivered through a device called PROPEAQ, may help to improve these challenging symptoms.

PROPEAQ are light therapy glasses. They were developed by a company called Chrono Eyewear, founded by healthcare professionals in the Netherlands. The glasses deliver blue light to the wearer via a series of LED lights that are built into the frame. The glasses are designed to improve the sleep-wake cycle, helping to improve sleep and increase energy levels during the day.

In a first-of-it's-kind study, researchers explored whether exposure to blue light can improve sleep and daytime sleepiness in people with Parkinson's.

What did the study involve?

Researchers at Radboud University in the Netherlands, led by Professor Bas Bloem, conducted a small clinical trial of the PROPEAQ light glasses involving 31 people with Parkinson's.

During the trial, participants were randomly assigned to wear either glasses that delivered blue light therapy, or glasses which delivered red light therapy. The study was single-blinded, meaning that only the researchers conducting the study knew which treatment each participant was receiving.

The participants wore the glasses for an hour, twice a day over the course of 2 weeks. Sleep quality and daytime sleepiness was measured 3 times: at the beginning of the study, after 2 weeks of blue or red light therapy, and again after 5 weeks.

What did they find?

The results show that the glasses were easy for people with Parkinson's to use, with most of the participants quickly learning to use the glasses by themselves. Most participants were positive about the glasses, and there were also no major side effects reported during the study.

In terms of sleep quality, the group using the blue light glasses reported that they slept better than the group using the red light glasses. Daytime sleepiness also improved significantly in the blue light group compared to the red light group, with levels of sleepiness falling from 50% to 7% after exposure to blue light.

Read the full published paper on the Journal of Parkinson's Disease website.

What does this mean for people with Parkinson's?

Emma Rodgers, Research Communications Manager at Parkinson's UK, shares:

"It's encouraging to see that blue light therapy may have potential to help people with Parkinson's sleep better and feel less sleepy during the day. We know that sleep troubles affect around 1 in 2 people with Parkinson's. As the therapy is delivered through wearable glasses, it may be a very practical way for people to manage difficulties with their sleep.

"That said, the study was small and participants were already users of the PROPEAQ light glasses, having bought the glasses themselves. This may have led to more positive results overall.We need to see bigger future studies to understand how blue light therapy may support sleep difficulties in Parkinson's."

At the moment, the PROPEAQ glasses are not available for purchase in the UK. Our Tech Guide contains a list of technology and gadgets that are currently available. Visit the Tech Guide to find out more.